The approval of neffy marks the first major advancement in epinephrine delivery for patients over four years of age in more than 35 years. The FDA has approved ARS Pharmaceuticals’ neffy 1 mg, an ...

ARS Pharmaceuticals, Inc, a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, ...